Skip to content Skip to navigation

Grants and Funding

Our lab receives funding from various sources that include the National Institutes of Health, philanthropic organizations, institutional organizations, and individual gifts. A list of current and past grants where we direct or collaborate on research projects is shown below.

Make a Gift

National Institutes of Health

NIH R01 EY026877
Inflammatory Gene Transcription in the Retina


NIH P30 EY030151
Stanford Vision Research Core

NIH R01 NS-98950
Exploring novel epilepsy pathways

NIH R01 AR59703
Genetic and immunologic etiology of chronic recurrent multifocal osteomylitis (CRMO)

NIH R01 EY-26682
Mechanistic studies on regenerative medicine approaches to childhood blindness

NIH R01 EY-24698
Gene silencing and gene editing in phototransduction

NIH R01 EY-24665
Structure and function of Calpain-5

NIH R01 EY-25225
Mechanism-based therapies for photoreceptor degeneration

NIH R21 AG-50437
Evaluating GWAS AMD candidate loci by gene editing in human IPS cells

NIH K08 EY020530
Molecular Genetics of Dominant Neovascular Inflammatory Vitreoretinopathy
02/01/11 – 01/31/16

Training Grants (NIH)

Bio-X Undergraduate Summer Research Program (Mentor)
Proteomics of Vitreoretinal Disease
06/2020 - 09/2020

ChEM-H Undergraduate Scholars Program (Mentor)
01/2020 - 09/2020

NIH F30 EY027986 (Mentor)
Structure-function studies of Calpain-5 in hereditary uveitis 
03/2018 - 03/2022

NIH-F31 EY026789-02 (Mentor)
CAPN5 –PDGF Signaling in Vitreoretinopathy

NIH 5F32EY022280 (Mentor)
Molecular Mechanisms of SOD3 and Oxidative Stress in Diabetic Vitreoretinopathy


Research to Prevent Blindness
Research Collaborations
9/2018 - 8/2022

Doris Duke Charitable Foundation
Clinical Scientist Development Award
Molecular Genetic Mechanisms of Calpain-5 Autoimmunity
7/2013 - 6/2017

Research to Prevent Blindness.
Molecular Genetics of ADNIV
9/2011 – 10/2016

Bright Focus
Cytokine Signaling in the Foveal Choroid in AMD
7/2011 – 6/2013

Fight for Sight
Molecular Genetics of Retinal Detachment
7/2009 – 6/2012

A.P. Giannini Foundation
7/2003 – 6/2005


Stanford Alliance for Innovative Medicines
Target-driven Drug Discovery
1/2019 - 12/2019

ChEM-H Testing Molecular Hypotheses in Human Subjects
Vitreous Proteases
3/2018 - 2/2019